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INTRODUCTION
Tumor necrosis factor (TNF), interleukin-1 (IL-
1), and matrix metalloproteases have been noted to
be elevated in human abdominal aortic aneurysms
(AAAs) as compared with normal and occlusive aor-
tic disease.1 Because TNF and IL-1 have been
shown to cause release of proteases that weaken the
aortic matrix, it has been suggested that these
cytokines may play a central role in the aortic dilata-
tion process. To substantiate this hypothesis, we
investigated the effects of TNF and IL-1 antago-
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nists, tumor necrosis factor binding protein (TNF-
BP) and interleukin-1 receptor antagonist (IL-1RA),
on the development of AAAs in a well-described rat
model.
IL-1 and TNF are proinflammatory cytokines
that have been noted to amplify inflammatory2 and
immunological injury.3 IL-1RA is a specific inhibitor
for IL-1 and is a 18 kd glycoprotein produced by
monocytes/macrophages and polymorphonuclear
cells.4, 5
TNF is predominately produced by macro-
phages/monocytes. TNF-BP is a polyethylene gly-
col-linked dimer of the shed form of type I TNF
receptor, and has also been found to be a specific
inhibitor of TNF.
MATERIALS AND METHODS
Male Wistar rats weighing 350–450 g were cared
for in accordance with the Guide for the Care and Use
of Laboratory Animals (Institute of Laboratory
Animal Resources, Commission on Life Sciences,
National Research Council. Washington: National
Academy Press 1996). This experiment was approved
by the Institutional Review Board of Maimonides
Medical Center. The rats were anesthetized with 50
mg/kg of intraperitoneal pentobarbital. All surgery
was performed under sterile conditions. The aorta,
inferior mesenteric artery, and the iliac arteries were
dissected. The inferior mesenteric artery was ligated.
The diameter of the aorta was measured three times
using a micrometer calibrated at .05 mm intervals
with microscopic assistance (10 x Wild Corporation,
Switzerland). The infrarenal aorta was catheterized
with a PE-10 polyethylene catheter via the left iliac
artery. The infrarenal aorta was isolated by placing
clamps caudal to the renal arteries and on bilateral
iliac arteries. The aorta was perfused with sterile pan-
creatic elastase (type I-hog; Sigma Chemical Co., St.
Louis, Mo.) at a concentration of 25 U/cc at a rate
of 1 cc/hr for two hours. At the end of the perfusion,
the aorta was unclamped, the catheter was removed,
and the left iliac artery was ligated. The animals
recovered in a warm humidified environment.6
In the treated group, eight rats were given intra-
venous TNF-BP (Amgen, Boulder, Colo.) at the
dose of 1 mg/kg diluted in vehicle (35 mmol/L
NaCl, 10 mmol/L NaH2PO4, and 4% sorbitol)
prior to elastase perfusion, at 48 hours and at 96
hours. In the control group, eight rats were given
only intravenous vehicle prior to elastase perfusion,
at 48 hours and at 96 hours. On the sixth postoper-
ative day all rats underwent celiotomy and three
measurements of the infrarenal aortic diameter with
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a micrometer while the animal was alive. The
infrarenal aorta was then harvested and divided into
quarters. One section was placed in formalin (10%),
and the remainder was frozen (-20%).
Isolated segments of infrarenal aorta of an addi-
tional 16 rats were perfused with porcine elastase in
a similar fashion. In the treated group, eight rats
were given intraperitoneal IL-1RA (Amgen) at the
dose of 100 mg/kg diluted in vehicle (10 mmol/L
Citrate pH 6.5, 140 mmol/L NaCl + .1% Tween)
20 minutes prior to celiotomy and every eight
hours. In the control group, eight rats were given
only intraperitoneal vehicle 20 minutes prior to
celiotomy and every eight hours. The dosages used
for TNF-BP and IL-1RA were based on previous
work in another rat model.7 On the sixth postoper-
ative day, all rats underwent celiotomy and three
measurements of the infrarenal aortic diameter with
a micrometer while the animal was alive. Specimens
were handled in a similar manner as with the TNF-
BP treated group. Gelatin gel zymography was car-
ried out as previously described.2 Briefly, after stan-
dard protein aliquots were assayed by the Bio-Rad
assay kit as per the manufacturer’s instructions, the
specimens were run on 10% gelatin gels under non-
reducing conditions and stained with Coumassie-
Blue. Statistical analysis was performed using
Student’s t-test or analysis of variance using the
Graphpad Instat 2.05a program. 
One additional rat treated with six days of the vehi-
cle for TNF-BP underwent a standard helical CAT scan
with intravenous Hypaque (2 cc/kg) with 3-D recon-
structions on an El Scint CT Twin CAT scanner. This
was compared with a CAT scan of a rat who had under-
gone six days of treatment with TNF-BP.
RESULTS 
TNF-BP. The mean diameters of the aortas of
vehicle-treated animals prior to elastase infusion,
immediate post-elastase infusion, and at six days
were 1.4 ± 0.038 mm (range 1.34–1.55 mm), 1.9 ±
0.14 mm (range 1.59–2.2 mm), and 2.71 ± 0.074
mm (range 2.66–2.8), respectively. The mean diam-
eters of the aortas of the TNF-BP–treated animals
prior to elastase infusion, immediate post-elastase
infusion, and at six days were 1.36 ± 0.067 mm
(range 1.2–1.54 mm), 1.91 ± 0.087 mm (range
1.87–2.01 mm), and 1.85 ± 0.137 mm, respective-
ly. This represents a 62% reduction in the mean
diameter in the treated animals vs. that of controls
when compared with pre-perfusion diameters (P
<0.0002 by two-tailed Student’s t-test) and com-
plete inhibition of the post-elastase dilatation.
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IL-1RA. The mean diameters of the aortas of
vehicle-treated animals prior to elastase infusion,
immediate post-elastase infusion, and at six days
were 1.4 ± 0.130 mm (range 1.25–1.66mm), 1.71 ±
0.112 mm (range 1.58-1.92 mm), and 2.2 ± 0.296
(range 2.09–2.62) mm, respectively. The mean
diameters of the aortas of the IL-1RA–treated ani-
mals prior to elastase infusion, immediate post-elas-
tase infusion, and at six days were 1.31 ± 0.152 mm
(range 1.1–1.66), 1.58 ± 0.131 mm (range
1.33–1.88), and 2.31 ± 0.178 mm (range 2.05–2.56
mm), respectively (P >0.05). No statistical differ-
ence in the diameters the rats treated with either
vehicle could be found (P = 0.10)(Figs. 1 and 2).
Aortic specimens were collected on day 6 for
hematoxylin and eosin staining, trichrome staining,
and gelatin gel PAGE zymography. Hematoxylin
and eosin staining and trichrome staining revealed
that animals treated with TNF-BP had less of an
inflammatory response (Figs. 3 and 4) with an aver-
age of 13.5 cells found on 10 random high-powered
fields of vehicle- or IL-1RA–treated animals as com-
Fig. 1. Change in diameter in rat aortas.
Fig. 2. 3-D CAT scan of normal aorta and aortic aneurysm in rat.
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pared with 0 cells found on 10 random high-pow-
ered fields of TNF-BP–treated animals. There was
preservation of the elastin and smooth muscles in
the media of the aortic wall as compared with ani-
mals treated with IL-1RA or vehicle (Figs. 5–8).
Zymography was not able to detect significant pro-
tease activity in the aortic wall of any of the rats at
six days. 
CONCLUSIONS
These data support the theory that TNF, but not
IL-1, may play a role in the development of AAAs,
perhaps by stimulating release of proteases. This is
somewhat surprising because TNF and IL-1 have
been found often to have similar effects in other
inflammatory and septic models. However, the lower
levels of IL-1 as compared with the levels of TNF
found in human AAA tissue suggests that IL-1 may
play less of a role in the pathogenesis of AAAs.
Previous studies have demonstrated TNF and IL-1
levels in human AAA tissue to be approximately 80
times and four times that of control tissue, respective-
ly, and have suggested that these cytokines may play a
role in helping coordinate the elaboration of pro-
teolytic enzymes from the inflammatory infiltrate that
is seen in aneurysmal tissue. Because TNF has been
shown to cause release of proteases from macrophages
in various models, we speculate that TNF-BP may be
inhibiting the release of proteases from the inflamma-
tory infiltrate known to occur in this model. Whereas
previous investigators have attenuated the growth of
the aneurysms in this experimental model using vari-
ous compounds such as propranolol,8 steroids,
cyclosporin,9 specific antibodies for adhesion mole-
cules,10 and Doxycycline,11 this is the first study using
specific cytokine antagonists.
One peculiar feature of the present study is the
comparatively small amount of dilatation after the
Fig. 3. A, Animals treated with IL-1RA had destruction of the elastin in the media of the aor-
tic wall (arrow). B, Animals treated with TNF-BP had preservation of the elastin in the media
of the aortic wall, as compared with animals treated with IL-1RA or vehicle (arrow).
C, Intense inflammatory response in animals treated with IL-1RA. There are fewer inflamma-
tory cells in B. D, Trichrome staining revealed that animals treated with TNF-BP had preser-
vation of the smooth muscle cells in the media of the aortic wall (arrow). E, Destruction of
smooth muscle cells in the aortic wall of animals treated with IL-1RA or vehicle (arrow). 
A, B, and C are stained with hematoxylin and eosin. D and E are stained with trichrome.
Magnified 400X.
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elastase perfusion. Others have reported as much as
300% dilatation by six days, whereas we observed
180% to 220% that of perfused aortic diameter.
Perhaps, the simplified technique that we used may
explain this; to avoid injury to the inferior vena cava,
we did not dissect, isolate, and clamp each lumbar
vessel to our aortic segments. This may have allowed
a small amount of flow in the aortic segment during
perfusion and led to less activity of the elastase on
the aortic wall. Nonetheless, the amount of dilata-
tion was consistent and reproducible.
Attempts to identify proteolytic activity by gelatin
zymography to elucidate the mechanism of TNF-BP
effect suggest that either inhibition of gelatinolytic
enzymes is not the major effect of TNF-BP in this
model or that the major proteolytic changes have
passed by day six. Perhaps by studying the tissues at
earlier time periods more insight on the specifics of
this model could be gained. 
In humans, it is believed that the inflammatory
infiltrate may elaborate these cytokines that cause
release of matrix-destructive proteases. The proteas-
es then weaken the aortic wall matrix, leading to
dilatation and formation of the aneurysm. Whereas
this rat model is quite different from a human AAA,
these data do suggest that TNF-BP has an extreme-
ly potent inhibitory effect (100%) on the dilatation
because of the secondary dilatation after the elastase
perfusion in this rat model. 
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